Your browser doesn't support javascript.
loading
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Jimenez-Fonseca, Paula; Carmona-Bayonas, Alberto; Martínez de Castro, Eva; Custodio, Ana; Pericay Pijaume, Carles; Hernandez, Raquel; Aguado, Gema; Castro Unanua, Natalia; Cano, Juana María; López, Flora; Garrido, Marcelo; Fernández Montes, Ana; Visa, Laura; Sánchez Cánovas, Manuel; Limón, María Luisa; Martínez Lago, Nieves; Pimentel, Paola; Hurtado, Alicia; Azkárate, Aitor; Longo, Federico; Diez, Marc; Arias-Martinez, Aranzazu; Sauri, Tamara; Martín Carnicero, Alfonso; Mangas, Monserrat; Martín Richard, Marta; Granja, Mónica; Ramchandani, Avinash; Hernández Pérez, Carolina; Cerdá, Paula; Gil-Negrete, Aitziber; Calvo, Mariona; Vidal Tocino, Rosario; Gallego, Javier.
Afiliação
  • Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Avenida Roma s/n, Oviedo, Spain. palucaji@hotmail.com.
  • Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, CP13/00126, PI17/0050 (ISCIII& FEDER), Murcia, Spain.
  • Martínez de Castro E; Fundación Séneca (04515/GERM/06), Murcia, Spain.
  • Custodio A; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Pericay Pijaume C; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain.
  • Hernandez R; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain.
  • Aguado G; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain.
  • Castro Unanua N; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Cano JM; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • López F; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • Garrido M; Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • Fernández Montes A; Medical Oncology Department, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
  • Visa L; Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain.
  • Sánchez Cánovas M; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain.
  • Limón ML; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain.
  • Martínez Lago N; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Pimentel P; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, Coruña, Spain.
  • Hurtado A; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain.
  • Azkárate A; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Longo F; Medical Oncology Department, Hospital Universitario Son Espases, Mallorca, Spain.
  • Diez M; Medical Oncology Department, Hospital Universitario Ramón and Cajal, Madrid, Spain.
  • Arias-Martinez A; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Sauri T; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Martín Carnicero A; Medical Oncology Department, Hospital Clinic, Barcelona, Spain.
  • Mangas M; Medical Oncology Department, Hospital San Pedro, Logroño, Spain.
  • Martín Richard M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain.
  • Granja M; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain.
  • Ramchandani A; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Hernández Pérez C; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Cerdá P; Medical Oncology Department, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain.
  • Gil-Negrete A; Medical Oncology Department, Centro Médico Tecknon, Barcelona, Spain.
  • Calvo M; Medical Oncology Department, Hospital Universitario de Donostia, San Sebastián, Spain.
  • Vidal Tocino R; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Spain.
  • Gallego J; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca, IBSAL, Salamanca, Spain.
Gastric Cancer ; 24(2): 445-456, 2021 Mar.
Article em En | MEDLINE | ID: mdl-32970266
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Ensaios Clínicos como Assunto / Docetaxel Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Ensaios Clínicos como Assunto / Docetaxel Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha